Let’s talk

Medical devices · Pharmaceutical and life sciences

Consignment and loaner stock for medical device companies, reconciled to every case

Much of a device company's inventory sits in hospitals, with dealers or in loaner sets moving between operating theatres. We reconcile that stock to usage and billing. Revenue is then not missed, and the inventory in the books is the inventory that exists.

In one paragraph

Medical device manufacturers and importers — implants, surgical instruments, disposables and consumables — usually turn over ₹15–300 crore and sell through dealers and directly to hospitals. In this trade, sale and usage are separated. Product is placed in advance, consumed during a procedure, and billed only once someone reports that it was used. Owners and finance heads, often with the sales operations lead, end up accounting for stock they cannot see.

Who usually engages us

Managing director or finance head, often with the sales operations lead

The economics

How the money moves in this trade

Implant and surgical device businesses commonly place consignment stock at hospitals and send loaner instrument sets for individual procedures. Revenue arises when a hospital reports consumption, which may be days or weeks after the case. Each set carries many sizes, and most come back unused. Every movement in and out of a hospital is a chance for stock to be lost, damaged or used without being billed.

Sales run through a mix of dealers, distributors and direct hospital accounts, each on different margins, credit terms and claim arrangements. Coronary stents carry a ceiling price, and the price regulator has at times capped trade margins on other devices. Imported devices also carry currency and customs cost. Product-family margin is therefore hard to read until every dealer claim, consignment shortage and freight charge is attached to the product that caused it.

The problem

Where the numbers usually break down

Consignment stock is counted rarely

Stock at hospitals is verified once a year, if that. Items used and not reported, expired or damaged go undetected until the count, when the loss is written off in a lump.

Loaner sets lose items between cases

Instrument sets come back incomplete and the missing pieces are replaced quietly from stock, so the cost of running the loaner programme is never measured.

Usage reports lag billing

Hospitals report consumption late or in batches, so revenue for a month is understated and the next month overstated, and some usage is never billed at all.

Dealer claims are settled on the dealer's figures

Price-difference, scheme and return claims from dealers are paid against the dealer's statement without being matched to the original sales and terms.

Service contract revenue is booked when invoiced

Annual maintenance and service contracts for capital equipment are billed in advance and recognised immediately, overstating the year in which they are sold.

What we do

The work, and the result each part produces

Consignment reconciliation by hospital

Stock placed, reported used, returned and on hand reconciled for each hospital on a fixed cycle, with variances investigated.

Consignment stock in the books matches what sits on hospital shelves.

Loaner-set tracking and costing

Each set's issue, return and missing items recorded by case, with replacement and sterilisation cost charged to the programme.

The real cost of supporting a procedure is known.

Usage-to-invoice matching

Hospital usage reports, case records and invoices matched so every consumed item is billed in the period it was used.

Revenue is complete and lands in the right month.

Dealer claims testing

Claims for price difference, schemes and returns matched to the original invoice, scheme terms and stock position before settlement.

Claims are paid on evidence rather than on the dealer's statement.

Product-family and channel margin

Contribution by product family and by dealer or direct channel, after claims, freight, consignment losses and import cost.

You can see which families and channels earn their working capital.

Service contract accounting

Maintenance and service contracts tracked by machine and recognised over the period of cover, with service cost set against them.

Service income is reported in the period it is earned.

Where we start

The first steps of an engagement

  1. Placement, case and claim records

    We ask for consignment placements by hospital, loaner-set issue and return logs, sales-team case records, hospital usage reports, the dealer claim register and the stock ledger.

  2. Reconciliation at the largest hospitals

    Starting with the hospitals holding the most value, we reconcile stock placed, reported used, returned and on hand. Each difference is traced to a case, a missing report or a loss.

  3. Usage matched to invoice

    Each case record is matched to the hospital's usage report and an invoice in the same period. Unbilled usage is raised, and every loaner-set return is checked against its contents list.

  4. Consignment and claims report

    The first report shows consignment stock reconciled by hospital, usage not yet billed, loaner-set losses, and dealer claims tested against the original sales and terms.

How it is measured

The reports the work is judged on

Each is recorded as a baseline before the work starts, so later reports have an honest comparison.

  • Consignment stock reconciled, by hospital
  • Loaner-set losses and replacement cost
  • Usage reported and billed within the month
  • Dealer claims raised, tested and settled
  • Contribution by product family and channel
  • Deferred service revenue and service cost by contract

Who it suits

Written for, and not the right fit for

Not the right fit if
  • You need help with device registration, licensing or classification; that sits with your regulatory team and the licensing authority.
  • You need a statutory audit or tax-audit report for the device business on its own — that is signed by an independently engaged CA.
Written for
  • Implant, surgical instrument and disposable device makers selling through dealers and hospitals.
  • Importers and distributors of devices carrying consignment and loaner stock.
  • Device businesses preparing for investment or a new manufacturing facility.

Common questions

Questions owners in this trade ask

How often should consignment stock be counted?

More often for high-value implants than for low-value disposables. A rolling count that covers the expensive items every month and the rest each quarter is usually enough to keep losses small and visible.

Will our sales team's case records do as evidence of usage?

Usually, yes. The case record is often the best evidence of usage. The work is in matching it to hospital reports and invoices consistently, not in creating a new form.

Do you help with device registration or licences?

No. Registration, licensing and classification sit with your regulatory team and the authority. We handle the finance side — inventory, claims, margin and controls.

Scope and professional coordination

5th Quadrant performs inventory reconciliation, costing, control and reporting work. Medical device registration, licensing, pricing compliance and quality-system matters are the responsibility of the manufacturer or importer and the relevant authorities. Statutory audit and prescribed certification are performed by independently engaged licensed professionals. Full detail is on our Professional Scope page.

Explore further

Other trades in this sector

API manufacturersAPI batch cost is usually read from a validation-era standard yield, and costing each campaign from the yield, solvent and changeover it consumed shows what each molecule really costs.View trade ↗Formulation manufacturersWhen one blended conversion rate covers every dosage form, small complex SKUs look cheap; costing each SKU by line, pack and price-control status puts the margin where it belongs.View trade ↗Contract development and manufacturingA CDMO usually learns a programme's margin only when the contract closes; costing each one against milestones, scientist hours and reserved capacity shows it while the work runs.View trade ↗Diagnostic equipmentAnalysers placed against reagent commitments are often judged on reagent sales alone; measuring each placement's return against the instrument it tied up shows which sites pay back.View trade ↗BiotechnologyReporting runway as one bank balance over one burn rate hides the real position; costing each programme and tying spend to grant and funding milestones gives the board a forecast.View trade ↗NutraceuticalsSupplement brands often read channel margin before marketplace fees, contract-manufacturer losses and short-dated stock; contribution by SKU and channel after all three shows what funds growth.View trade ↗Pharmaceutical distributionPharma distributors earn on thin trade margins and lose them on unrecovered expiry and scheme claims, which a monthly reconciliation with each principal brings back into view.View trade ↗
Back to Pharmaceutical and life sciences ↗

Tell us how your business actually runs.

Discuss your requirements